Researchers have developed a new, highly effective “gene switch” to deliver targeted cell therapy.

The ETH Zurich team states that this cell therapy has the potential to offer a more precise and personalized treatment for diabetes.

Diabetes is a major global health concern, classified as a metabolic disease and affecting about one in ten individuals.